Pay in 4 interest-free payments of $17.25 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
195(1):298-306
Dovitinib (50 and 75 mg/kg) results in 97% and 98% tumor growth inhibition
which is structurally an analogue of naproxen
MPI-0479605 (0
Bryan King
GSK-2981278 - CAS# 1474110-21-8 Catalog No.:M6485-10 195(1):298-306GSK 2981278, CAS No. 1474110 21 8, is a highly potent and selective inverse agonist of retinoic acid receptor related orphan receptor gamma (ROR gamma). GSK 2981278 is a strong ROR selective inverse agonist that inhibits activation of the il17 promoter. GSK 2981278 robustly inhibits ROR mediated cytokine production at both the mRNA and protein level. GSK 2981278 attenuates inflammation in a mouse model of psoriasis. Topical treatment with GSK 2981278
US$ 139.99
US$ 27.00